Discover 1,928 paid clinical trials in Plano, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,928
Featured
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
for
Neovascular Age-related Macular Degeneration
Location: Burleson TX, Round Rock TX, Abilene TX, Austin TX,
Sponsor: AbbVie
Sex: All
Age: 50+
Code: NCT07007065
Phase3, Recruiting
Active & Responsive
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
for
Metastatic Non-small Cell Lung Cancer
Location: Richardson TX, Dallas TX, Houston TX, San Antonio TX,
Sponsor: NovoCure GmbH
Sex: All
Age: 18+
Code: NCT06216301
Phase3, Recruiting
Active & Responsive
Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis
for
Atopic Dermatitis (AD), Psoriasis (PsO)
Location: Dallas TX, Fargo ND
Sponsor: LAPIX Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT06982352
Phase1, Recruiting
Active & Responsive
CLIKX® Tympanostomy Tube Delivery System for the Placement of Tympanostomy Tubes
for
Otitis Media, Otitis Media Chronic, Otitis Media Effusion,
Location: Mesquite TX, Louisville KY
Sponsor: ClinQure, Inc.
Sex: All
Age: 0+
Code: NCT07625657
Recruiting
Active & Responsive
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
for
Atopic Dermatitis
Location: Dallas TX, Frisco TX, San Antonio TX, Nashville TN,
Sponsor: Apogee Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07003425
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
for
Ulcerative Colitis
Location: Garland TX, Fort Worth TX, Tyler TX, Cedar Park TX,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07186101
Phase2, Recruiting
Active & Responsive
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine